Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation
Vinai Bhagirath, Tanya Kovalova, Jia Wang, Lizhen Xu, Shrikant I. Bangdiwala, Martin O'Donnell, Ashkan Shoamanesh, Jackie Bosch, Rosa Coppolecchia, Tatsiana Vaitsiakhovich, Frank Kleinjung, Hardi Mundl, John Eikelboom
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntiplatelet Therapy and Cardiovascular Diseases · Venous Thromboembolism Diagnosis and Management · Heparin-Induced Thrombocytopenia and Thrombosis
It has been brought to the publisher's attention that the author “Rosa Coppolecchia's” affiliation was changed to “Bayer US LLC, Whippany, New Jersey, United States” in the version of the above article in TH Open , published in Volume 8, Number 1 ( 10.1055/a-2259-1134 ). The updated authors list and the affiliations has been corrected as given above.